These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9572282)

  • 1. Enhanced [3H]DOPA and [3H]dopamine turnover in striatum and frontal cortex in vivo linked to glutamate receptor antagonism.
    Reith J; Cumming P; Gjedde A
    J Neurochem; 1998 May; 70(5):1979-85. PubMed ID: 9572282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in the adult rat.
    Gorter JA; Botterblom MH; Feenstra MG; Boer GJ
    Neurosci Lett; 1992 Mar; 137(1):97-100. PubMed ID: 1320756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro.
    Jones CA; Zempléni E; Davis B; Reynolds GP
    Eur J Pharmacol; 1993 Sep; 242(2):183-7. PubMed ID: 7902812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between dopamine and glutamate receptors following treatment with NMDA receptor antagonists.
    Vasiliadis HM; Elie R; Dewar KM
    Eur J Pharmacol; 1999 Dec; 386(2-3):155-63. PubMed ID: 10618465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A further evaluation of the effects of K+ depolarization on glutamate-evoked [3H]dopamine release from striatal slices.
    Bowyer JF; Newport GD; Lipe GW; Frame LT
    J Pharmacol Exp Ther; 1992 Apr; 261(1):72-80. PubMed ID: 1348539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediation of ionotropic glutamate receptors in domoic acid-induced striatal dopamine release in rats.
    Quintela BA; Durán R; Alfonso M
    Eur J Pharmacol; 2000 Aug; 401(2):173-7. PubMed ID: 10924923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2002 Feb; 926(1-2):149-55. PubMed ID: 11814417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Nov; 407(3):281-91. PubMed ID: 11068024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutamate receptors and nitric oxide on the effects of glufosinate ammonium, an organophosphate pesticide, on in vivo dopamine release in rat striatum.
    Faro LR; Ferreira Nunes BV; Alfonso M; Ferreira VM; Durán R
    Toxicology; 2013 Sep; 311(3):154-61. PubMed ID: 23810826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum.
    Fedele E; Versace P; Raiteri M
    Eur J Pharmacol; 1993 Nov; 249(1):71-7. PubMed ID: 7506667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glutamate and MK-801 on the metabolism of dopamine in the striatum of normal and parkinsonian rats.
    Duan CL; Sun XH; Ji M; Yang H
    Sheng Li Xue Bao; 2005 Feb; 57(1):71-6. PubMed ID: 15719139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of MK-801 with glutamate-, glutamine- and methamphetamine-evoked release of [3H]dopamine from striatal slices.
    Bowyer JF; Scallet AC; Holson RR; Lipe GW; Slikker W; Ali SF
    J Pharmacol Exp Ther; 1991 Apr; 257(1):262-70. PubMed ID: 1673475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
    Robinson S; Krentz L; Moore C; Meshul CK
    Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptors inhibit the mild hypoxia-induced dopamine efflux in the rat striatum.
    Orset C; Parrot S; Sauvinet V; Cottet-Emard JM; Pequignot JM; Denoroy L
    Synapse; 2006 Jun; 59(7):458-61. PubMed ID: 16523475
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamate receptor binding in the frontal cortex and dorsal striatum of aged rats with impaired attentional set-shifting.
    Nicolle MM; Baxter MG
    Eur J Neurosci; 2003 Dec; 18(12):3335-42. PubMed ID: 14686906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.